Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Chemomab Therapeutics Ltd ADR
(NQ:
CMMB
)
0.7610
-0.0090 (-1.17%)
Streaming Delayed Price
Updated: 10:48 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
919
Open
0.7700
Bid (Size)
0.7320 (2)
Ask (Size)
0.7700 (12)
Prev. Close
0.7700
Today's Range
0.7600 - 0.7700
52wk Range
0.4200 - 1.770
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
March 25, 2024
From
Chemomab Therapeutics
Via
GlobeNewswire
CMMB Stock Earnings: Chemomab Therapeutics Reported Results for Q4 2023
March 07, 2024
Chemomab Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
+41.50%
+41.50%
1 Month
+13.58%
+13.58%
3 Month
+43.61%
+43.61%
6 Month
-16.37%
-16.37%
1 Year
-52.44%
-52.44%
More News
Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 21, 2024
Via
Benzinga
A Preview Of Chemomab Therapeutics's Earnings
March 30, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 20, 2024
Via
Benzinga
What's Going On With Fibro-Inflammatory Disease Focused Chemomab Therapeutics On Tuesday?
February 20, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why M.D.C. Holdings Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
January 18, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 18, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 29, 2023
Via
InvestorPlace
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 16, 2023
Via
Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
November 16, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 16, 2023
Via
InvestorPlace
Crude Oil Falls 2%; TJX Issues Weak Earnings Outlook
November 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
US Stocks Gain; Producer Prices Fall In October
November 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why is Liver Disease Focused Chemomab Stock Trading Higher Today?
November 15, 2023
Via
Benzinga
Exposures
Product Safety
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 15, 2023
Via
Benzinga
What's Going On With Chemomab Therapeutics Stock Today
June 21, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
June 07, 2023
Via
Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 22, 2023
Via
Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.